You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, non-Hodgkin

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma Trial in Shanghai (dualCAR-NK19/70 cell)

Recruiting
  • Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
  • dualCAR-NK19/70 cell
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital, Tongji University School of Medicine
Apr 24, 2023

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)

Not yet recruiting
  • Lymphoma, Non-Hodgkin Lymphoma, B-Cell
  • BAFF CAR-T
  • (no location specified)
Aug 16, 2022

(CHANT)Real World Study of Duvelisib in Treatment of

Not yet recruiting
  • Follicular Lymphoma
  • +5 more
  • (no location specified)
Jun 20, 2023

Non Hodgkin Lymphoma Trial in Philadelphia (Pembrolizumab)

Recruiting
  • Non Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abamson Cancer Center of the University of Pennsylvania
Jan 9, 2023

Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)

Not yet recruiting
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Beijing, China
  • +3 more
Jul 20, 2023

CD20-positive B-cell Non-Hodgkin's Lymphoma Trial in Beijing (IMM0306)

Recruiting
  • CD20-positive B-cell Non-Hodgkin's Lymphoma
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Apr 6, 2023

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +6 more
  • (no location specified)
Apr 12, 2023

Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    Sep 9, 2022

    Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive

    Active, not recruiting
    • Aggressive B-Cell Non-Hodgkin Lymphoma
    • fractionated first dose rituximab
    • Geneva, Switzerland
      University Hospital Geneva
    Apr 21, 2023

    Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

    Enrolling by invitation
    • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
    • Suzhou, Jiangsu, China
      the First Affiliated Hospital of Soochow University
    Mar 22, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • +6 more
    • Bridging radiation therapy
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • Non-Hodgkin Lymphoma
    • San Antonio, Texas
      NEXT Oncology
    Jan 6, 2023

    Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • Relapsed Non-Hodgkin Lymphoma
    • SIRPant-M
    • External-beam radiotherapy (XRT)
    • Duarte, California
    • +2 more
    Jul 21, 2023

    Living Conditions After Non-Hodgkin's Lymphoma in France

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Data collection
    • Questionnaires
    • Dijon, France
      Chu Dijon Bourgogne
    Oct 13, 2022

    Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)

    Not yet recruiting
    • Non-Hodgkin's Lymphoma, Relapsed
    • +2 more
    • (no location specified)
    Dec 6, 2022

    Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

    Not yet recruiting
    • COVID-19
    • +2 more
      • Cologne, NRW, Germany
        University Hospital of Cologne
      Oct 27, 2022

      Advanced Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Multiple Myeloma Trial in Gyeonggi-do,

      Recruiting
      • Advanced Solid Tumors
      • +2 more
      • GIC-102 (Allogeneic NK cells)
      • Gyeonggi-do, Korea, Republic of
      • +3 more
      May 18, 2023

      B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma
      • +4 more
      • (no location specified)
      Dec 7, 2022

      B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • CB dualCAR-NK19/70
      • Hanzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Dec 25, 2022

      LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

      Not yet recruiting
      • Relapsed Non-Hodgkin Lymphoma
        • (no location specified)
        Sep 19, 2023

        Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

        Not yet recruiting
        • Non-Hodgkin Lymphoma
        • Large B-cell Lymphoma
        • Axicabtagene Ciloleucel
        • Palo Alto, California
          Stanford University
        Mar 20, 2023

        CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)

        Terminated
        • CD20-positive Non-Hodgkin Lymphoma
        • Rituximab + MG4101
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Oct 24, 2022

        NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

        Recruiting
        • NHL
        • NHL, Relapsed, Adult
        • Birmingham, Alabama
        • +4 more
        May 31, 2023

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • +6 more
        • Miltenyi CliniMACS Prodigy ® system
        • (no location specified)
        Mar 23, 2023